Updated Jul 16, 2026
Stansky Michael P has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $3.01M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 200.0K | $2.50 | $500K |
| 2026-05-18 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 410.0K | $2.50 | $1.02M |
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 20.1K | $0.00 | |
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 23.5K | $0.00 | |
| 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 117.2K | $4.10 | $481K |
| 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 243.9K | $4.10 | $1000K |
Stansky Michael P is a corporate insider — currently tracked as Director of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($3.01M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stansky Michael P profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.